PARD6G expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.427800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.055200E-01
Normal-vs-Stage2
9.425600E-01
Normal-vs-Stage3
8.732400E-01
Normal-vs-Stage4
7.338600E-01
Stage1-vs-Stage2
3.494400E-01
Stage1-vs-Stage3
5.623600E-01
Stage1-vs-Stage4
2.141800E-01
Stage2-vs-Stage3
8.137800E-01
Stage2-vs-Stage4
5.242600E-01
Stage3-vs-Stage4
9.426000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.091600E-01
Normal-vs-AfricanAmerican
8.943000E-01
Normal-vs-Asian
7.041800E-01
Caucasian-vs-AfricanAmerican
9.692000E-01
Caucasian-vs-Asian
5.721600E-01
AfricanAmerican-vs-Asian
7.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.923800E-01
Normal-vs-Female
9.748200E-01
Male-vs-Female
5.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.114800E-01
Normal-vs-Age(41-60Yrs)
8.326200E-01
Normal-vs-Age(61-80Yrs)
9.306000E-01
Normal-vs-Age(81-100Yrs)
4.925000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.572100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.217000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.792800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.144600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.168400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.130000E-01
Normal-vs-Daily Drinker
2.504600E-01
Normal-vs-Weekly Drinker
5.893200E-01
Normal-vs-Occasional Drinker
9.840800E-01
Normal-vs-Social Drinker
7.214400E-01
Non Drinker-vs-Daily Drinker
7.152000E-01
Non Drinker-vs-Weekly Drinker
1.139590E-02
Non Drinker-vs-Occasional Drinker
3.039000E-01
Non Drinker-vs-Social Drinker
7.420200E-02
Daily Drinker-vs-Weekly Drinker
1.981920E-02
Daily Drinker-vs-Occasional Drinker
2.157600E-01
Daily Drinker-vs-Social Drinker
4.774100E-02
Weekly Drinker-vs-Occasional Drinker
3.822400E-01
Weekly Drinker-vs-Social Drinker
8.071200E-01
Occasional Drinker-vs-Social Drinker
5.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.690600E-01
Normal-vs-Grade 2
2.447800E-01
Normal-vs-Grade 3
4.152000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.110100E-02
Grade 1-vs-Grade 3
3.057000E-01
Grade 1-vs-Grade 4
5.690600E-01
Grade 2-vs-Grade 3
4.403800E-01
Grade 2-vs-Grade 4
2.447800E-01
Grade 3-vs-Grade 4
4.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.370200E-01
Normal-vs-NonDiabetic
8.858000E-01
Diabetic-vs-NonDiabetic
8.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.374000E-01
Normal-vs-NoPancreatitis
9.318800E-01
Pancreatitis-vs-NoPancreatitis
9.907200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.520800E-01
Normal-vs-N1
9.958000E-01
N0-vs-N1
5.110400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.011000E-01
Normal-vs-TP53-NonMutant
7.701800E-01
TP53-Mutant-vs-TP53-NonMutant
9.963800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
